PHAT Phathom Pharmaceuticals, Inc. - Common Stock
$9,67
Kurs · Aug 19, 2026
Fundamentaldaten per Jul 30, 2026
52W-Spanne
$8–$18
14% of range
Analystenbewertung
BUY
17 analysts
Kursziel
$22
+122% upside
P/E (TTM)
-3.5
ROE
52.4%
Nettogewinnmarge
-126.4%
PHAT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$9.67
Marktkapitalisierung
$768M
P/E (TTM)
-3.5
EPS (TTM)
$-3.03
Umsatz (TTM)
$175M
Dividendenrendite
—
ROE
52.4%
Verschuldungsgrad
-0.5
52W-Spanne
$8 – $18
PHAT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$175M
2022-12-31
→
2025-12-31
EPS
$-3.03
2021-12-31
→
2025-12-31
Freier Cashflow
$-167M
2019-12-31
→
2025-12-31
Margen
-126.4%
2023-12-31
→
2025-12-31
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
PHAT
Peer-Median
P/E (TTM)
-3.5
11.7
P/S (TTM) (K/V (TTM))
4.4
5.4
P/B (K/B)
-1.8
3.7
EV / EBITDA
-5.3
—
Price / FCF (Kurs / FCF)
-4.6
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
PHAT
Peer-Median
Gross Margin (Bruttogewinnmarge)
87.1%
83.9%
Operating Margin (Betriebsgewinnmarge)
-91.4%
—
Net Profit Margin (Nettogewinnmarge)
-126.4%
-45.6%
ROA
-69.4%
-25.4%
ROE
52.4%
-27.1%
ROIC
69.8%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
PHAT
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
-0.5
—
Current Ratio (Liquiditätsgrad)
1.7
4.6
Quick Ratio
1.6
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
PHAT
Peer-Median
Revenue YoY (Umsatz YoY)
216.9%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
PHAT
Peer-Median
PHAT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
17 Analysten
- Starker Kauf 6 35,3%
- Kauf 9 52,9%
- Halten 2 11,8%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-08-18
Median
$21.50
← Unter allen Zielen
$9.67
Tief
$13.00
Hoch
$29.00
Median-Ziel
$21.50
+122,3%
Mittelwert-Ziel
$21.50
+122,3%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.02%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.21 | $-0.26 | 0.05% |
| 31. März 2026 | $-0.37 | $-0.33 | -0.04% |
| 31. Dezember 2025 | $-0.29 | $-0.39 | 0.10% |
| 30. September 2025 | $-0.41 | $-0.56 | 0.15% |
| 30. Juni 2025 | $-1.05 | $-1.06 | 0.01% |
| 31. März 2025 | $-1.31 | $-1.17 | -0.14% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | — |
| SGP | — | — | — | — | 50.0% | — |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | — |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $175M | $55M | $682.0K | $0 | |
| Cost of Revenue | $23M | $8M | $167.0K | $0 | |
| Gross Profit | $153M | $47M | $515.0K | $0 | |
| R&D Expense | $33M | $34M | $50M | $71M | |
| SG&A Expense | $280M | $291M | $118M | $101M | |
| Operating Expenses | $312M | $325M | $168M | $172M | |
| Operating Income | $-160M | $-277M | $-167M | $-172M | |
| Interest Expense | · | · | $42M | $27M | |
| Interest Income | $7M | $15M | $8M | $2M | |
| Other Non-op | $-190.0K | $-8.0K | $-188.0K | $-110.0K | |
| Pretax Income | $-221M | $-334M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-221M | $-334M | $-202M | $-198M | |
| EPS (Basic) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | |
| EPS (Diluted) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | |
| Shares (Basic) | 72,918,764 | 63,176,210 | 51,289,092 | 39,118,215 | |
| Shares (Diluted) | 72,918,764 | 63,176,210 | 51,289,092 | 39,118,215 | |
| EBITDA | $-159M | $-277M | $-167M | $-172M |
Bilanz 24
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $130M | $297M | $381M | $155M | |
| Receivables | $78M | $39M | $2M | $0 | |
| Inventory | $6M | $3M | $1M | $0 | |
| Prepaid Expense | $15M | $21M | $13M | $5M | |
| Current Assets | $229M | $360M | $397M | $161M | |
| PP&E (Net) | $1M | $1M | $2M | $1M | |
| PP&E (Gross) | $5M | $4M | $4M | $3M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | |
| Other Non-current Assets | $3M | $2M | $2M | $299.0K | |
| Total Assets | $259M | $378M | $414M | $165M | |
| Accounts Payable | $5M | $11M | $13M | $10M | |
| Accrued Liabilities | $90M | $53M | $17M | $15M | |
| Current Liabilities | $132M | $86M | $39M | $26M | |
| Capital Leases | $2M | · | $462.0K | $1M | |
| Other Non-current Liabilities | $4M | $12M | $10M | $8M | |
| Total Liabilities | $697M | $632M | $487M | $240M | |
| Long-term Debt | $209M | $201M | $138M | $95M | |
| Total Debt | $209M | $201M | $138M | $95M | |
| Common Stock | $6.0K | $6.0K | $5.0K | $3.0K | |
| Retained Earnings | $-1.48B | $-1.26B | $-929M | $-727M | |
| Treasury Stock | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $-438M | $-254M | $-73M | $-75M | |
| Liabilities + Equity | $259M | $378M | $414M | $165M | |
| Shares Outstanding | 71,419,025 | 68,518,238 | 57,970,044 | 41,468,871 |
Cashflow 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $633.0K | $795.0K | $575.0K | $620.0K | |
| Stock-based Comp | $29M | $24M | $45M | $24M | |
| Other Non-cash | $25M | $43M | $18M | $26M | |
| Operating Cash Flow | $-167M | $-267M | $-138M | $-147M | |
| CapEx | $229.0K | $135.0K | $2M | $1M | |
| Investing Cash Flow | $-229.0K | $-135.0K | $-2M | $-1M | |
| Debt Issued | $0 | $59M | $39M | $0 | |
| Net Debt Issued | $0 | $59M | $39M | · | |
| Stock Issued | · | · | $14M | · | |
| Financing Cash Flow | $-288.0K | $183M | $368M | $120M | |
| Net Change in Cash | $-167M | $-84M | $228M | $-28M | |
| Free Cash Flow | $-167M | $-267M | $-139M | $-148M |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 87.1% | 85.6% | 75.5% | · | |
| Operating Margin | -91.4% | -502.2% | -24532.5% | · | |
| Net Margin | -126.4% | -605.1% | -29558.9% | · | |
| Pretax Margin | -126.4% | · | · | · | |
| EBITDA Margin | -91.0% | -500.8% | -24448.2% | · | |
| ROA | -69.4% | -84.4% | -69.7% | -111.6% | |
| ROE | 52.4% | 151.7% | 445.4% | 390.6% | |
| ROIC | 69.8% | · | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.7 | 4.2 | 10.2 | 6.1 | |
| Quick Ratio | 1.6 | 3.9 | 9.9 | 5.9 | |
| Debt / Equity | -0.5 | -0.8 | -1.9 | -1.3 | |
| LT Debt / Equity | -0.5 | -0.8 | -1.9 | -1.3 | |
| Interest Coverage | · | · | -4.0 | -6.3 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.1 | 0.0 | · | |
| Inventory Turnover | 5.2 | 3.6 | 0.3 | · | |
| Receivables Turnover | 3.0 | 2.7 | 0.8 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 216.9% | 8001.5% | · | · |
Bewertung (TTM) 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $175M | $55M | $682.0K | $0 | |
| Net Income TTM | $-221M | $-334M | $-202M | $-198M | |
| Market Cap | $1.18B | $471M | $529M | $465M | |
| Enterprise Value | $1.26B | $375M | $286M | $405M | |
| P/E | -5.5 | -1.5 | -2.3 | -2.2 | |
| P/S | 6.8 | 8.5 | 776.1 | · | |
| P/B | -2.7 | -1.9 | -7.3 | -6.2 | |
| P / Cash Flow | -7.1 | -1.8 | -3.8 | -3.2 | |
| P / FCF | -7.1 | -1.8 | -3.8 | -3.2 | |
| EV / EBITDA | -7.9 | -1.4 | -1.7 | -2.4 | |
| EV / FCF | -7.6 | -1.4 | -2.1 | -2.7 | |
| EV / Revenue | 7.2 | 6.8 | 418.9 | · | |
| Earnings Yield | -18.3% | -65.1% | -43.0% | -45.0% |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $74M | $58M | $58M | $50M | $40M | $29M | $30M | $16M | $7M | $2M | $682.0K | $0 | $0 | $0 | |
| Cost of Revenue | $15M | $12M | $8M | $6M | $5M | $4M | $4M | $2M | $1M | $426.0K | $167.0K | $0 | $0 | $0 | |
| Gross Profit | $59M | $46M | $50M | $43M | $34M | $25M | $26M | $14M | $6M | $1M | $515.0K | $0 | $0 | $0 | |
| R&D Expense | $8M | $8M | $7M | $7M | $9M | $9M | $9M | $9M | $7M | $9M | $13M | $12M | $13M | $11M | |
| SG&A Expense | $55M | $54M | $48M | $52M | $85M | $94M | $77M | $76M | $76M | $62M | $57M | $23M | $19M | $19M | |
| Operating Expenses | $63M | $62M | $56M | $59M | $94M | $104M | $85M | $85M | $83M | $71M | $70M | $36M | $32M | $30M | |
| Operating Income | $-4M | $-15M | $-6M | $-15M | $-60M | $-79M | $-59M | $-71M | $-77M | $-70M | $-70M | $-36M | $-32M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | $18M | $17M | · | $10M | $10M | $9M | |
| Interest Income | $2M | $2M | $1M | $1M | $2M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | $348.0K | $1M | |
| Other Non-op | $-24.0K | $-831.0K | $-6.0K | $-7.0K | $-155.0K | $-22.0K | $49.0K | $-8.0K | $-6.0K | $-43.0K | $-14.0K | $-197.0K | $3.0K | $20.0K | |
| Net Income | $-18M | $-30M | $-21M | $-30M | $-76M | $-94M | $-74M | $-86M | $-91M | $-83M | $-80M | $-43M | $-41M | $-38M | |
| EPS (Basic) | $-0.21 | $-0.37 | $-0.26 | $-0.41 | $-1.05 | $-1.31 | $-0.99 | $-1.32 | $-1.56 | $-1.42 | $-1.44 | $-0.76 | $-0.84 | $-0.89 | |
| EPS (Diluted) | $-0.21 | $-0.37 | $-0.26 | $-0.41 | $-1.05 | $-1.31 | $-0.99 | $-1.32 | $-1.56 | $-1.42 | $-1.44 | $-0.76 | $-0.84 | $-0.89 | |
| Shares (Basic) | 83,747,104 | 82,050,618 | -144,913,285 | 73,396,435 | 72,466,203 | 71,969,411 | -118,381,262 | 64,627,847 | 58,558,145 | 58,371,480 | -96,348,323 | 56,782,379 | 48,500,516 | 42,354,520 | |
| Shares (Diluted) | 83,747,104 | 82,050,618 | -144,913,285 | 73,396,435 | 72,466,203 | 71,969,411 | -118,381,262 | 64,627,847 | 58,558,145 | 58,371,480 | -96,348,323 | 56,782,379 | 48,500,516 | 42,354,520 | |
| EBITDA | $-4M | $-15M | · | $-15M | $-60M | $-79M | · | $-71M | $-77M | $-70M | · | $-36M | $-32M | $-30M |
Bilanz 24
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $182M | $181M | $130M | $135M | $150M | $212M | $297M | $335M | $276M | $322M | $381M | $214M | $249M | $130M | |
| Receivables | $97M | $81M | $78M | $56M | $51M | $36M | $39M | $21M | $11M | $4M | $2M | · | · | · | |
| Inventory | $8M | $7M | $6M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $1M | $111.0K | $111.0K | · | |
| Prepaid Expense | $8M | $8M | $15M | $13M | $15M | $13M | $21M | $15M | $15M | $13M | $13M | $13M | $9M | $10M | |
| Current Assets | $296M | $277M | $229M | $208M | $219M | $265M | $360M | $374M | $305M | $340M | $397M | $227M | $258M | $140M | |
| PP&E (Net) | $971.0K | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| PP&E (Gross) | · | · | $5M | · | · | · | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $299.0K | |
| Total Assets | $327M | $305M | $259M | $240M | $250M | $294M | $378M | $387M | $319M | $356M | $414M | $237M | $265M | $144M | |
| Accounts Payable | $5M | $6M | $5M | $1M | $4M | $12M | $11M | $7M | $8M | $8M | $13M | $6M | $4M | $5M | |
| Accrued Liabilities | $109M | $83M | $90M | $65M | $64M | $43M | $53M | $36M | $27M | $17M | $17M | $13M | $15M | $8M | |
| Current Liabilities | $154M | $125M | $132M | $93M | $92M | $74M | $86M | $65M | $47M | $43M | $39M | $24M | $22M | $14M | |
| Capital Leases | $2M | $2M | $2M | $2M | $589.0K | $0 | · | $0 | $133.0K | $292.0K | $462.0K | $628.0K | $789.0K | $945.0K | |
| Other Non-current Liabilities | $4M | $4M | $4M | $12M | $12M | $12M | $12M | $11M | $10M | $10M | $10M | $8M | $8M | $8M | |
| Total Liabilities | $671M | $642M | $697M | $663M | $656M | $633M | $632M | $574M | $553M | $505M | $487M | $255M | $247M | $234M | |
| Long-term Debt | $165M | $164M | $209M | $207M | $205M | $203M | $201M | $176M | $174M | $149M | $138M | $99M | $98M | $97M | |
| Total Debt | $165M | $164M | · | $207M | $205M | $203M | · | $176M | $174M | $149M | · | $99M | $98M | $97M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | |
| Retained Earnings | $-1.53B | $-1.51B | $-1.48B | $-1.46B | $-1.43B | $-1.36B | $-1.26B | $-1.19B | $-1.10B | $-1.01B | $-929M | $-849M | $-806M | $-765M | |
| Treasury Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $-344M | $-337M | $-438M | $-423M | $-406M | $-338M | $-254M | $-187M | $-234M | $-149M | $-73M | $-18M | $18M | $-90M | |
| Liabilities + Equity | $327M | $305M | $259M | $240M | $250M | $294M | $378M | $387M | $319M | $356M | $414M | $237M | $265M | $144M | |
| Shares Outstanding | 80,070,048 | 79,442,367 | 71,419,025 | 71,043,149 | 70,104,419 | 69,638,070 | 68,518,238 | 68,323,938 | 58,601,025 | 58,524,101 | 57,970,044 | 56,809,085 | 56,639,085 | 43,571,140 |
Cashflow 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $114.0K | $110.0K | $128.0K | $156.0K | $172.0K | $177.0K | $193.0K | $191.0K | $197.0K | $214.0K | $185.0K | $121.0K | $123.0K | $146.0K | |
| Stock-based Comp | $7M | $6M | $6M | $9M | $8M | $6M | $7M | $6M | $6M | $6M | $25M | $6M | $7M | $7M | |
| Other Non-cash | · | $9M | · | · | · | $4M | · | · | · | $8M | · | · | · | $-9M | |
| Operating Cash Flow | $-2M | $-16M | $-5M | $-14M | $-63M | $-85M | $-63M | $-64M | $-71M | $-69M | $-44M | $-32M | $-22M | $-40M | |
| CapEx | $44.0K | $61.0K | $87.0K | $27.0K | $97.0K | $18.0K | $5.0K | $44.0K | $46.0K | $40.0K | $475.0K | $939.0K | $6.0K | $214.0K | |
| Investing Cash Flow | $-44.0K | $-61.0K | $-87.0K | $-27.0K | $-97.0K | $-18.0K | $-5.0K | $-44.0K | $-46.0K | $-40.0K | $-475.0K | $-939.0K | $-6.0K | $-214.0K | |
| Debt Issued | $0 | $173M | $0 | $0 | $0 | $0 | $25M | $0 | $25M | $10M | $39M | $0 | $0 | $0 | |
| Net Debt Issued | · | $-56M | · | · | · | $0 | · | · | · | $10M | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $4M | $67M | $-97.0K | $-271.0K | $80.0K | $0 | $26M | $122M | $25M | $10M | $212M | $13.0K | $142M | $14M | |
| Net Change in Cash | $2M | $51M | $-5M | $-14M | $-63M | $-85M | $-37M | $58M | $-46M | $-59M | $168M | $-33M | $119M | $-26M | |
| Free Cash Flow | · | $-16M | · | · | · | $-85M | · | · | · | $-69M | · | · | · | $-40M |
Rentabilität 6
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 79.7% | 79.4% | · | 87.5% | 87.2% | 86.9% | · | 85.6% | 81.2% | 77.7% | · | · | · | · | |
| Operating Margin | -5.3% | -26.6% | · | -30.9% | -151.7% | -276.5% | · | -433.0% | -1055.4% | -3658.7% | · | · | · | · | |
| Net Margin | -23.7% | -52.1% | · | -60.6% | -191.9% | -330.7% | · | -523.3% | -1248.6% | -4333.3% | · | · | · | · | |
| EBITDA Margin | -5.3% | -26.4% | · | -30.9% | -151.7% | -275.9% | · | -433.0% | -1055.4% | -3647.5% | · | · | · | · | |
| ROA | -6.1% | -10.1% | · | -9.6% | -26.6% | -29.0% | · | -27.4% | -31.3% | -33.1% | · | -19.7% | -17.1% | -25.8% | |
| ROE | 4.7% | 9.0% | · | 9.8% | 23.7% | 38.7% | · | 83.5% | 84.6% | 69.4% | · | 195.7% | -772.9% | 145.0% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 2.2 | · | 2.2 | 2.4 | 3.6 | · | 5.7 | 6.5 | 7.8 | · | 9.5 | 12.0 | 9.7 | |
| Quick Ratio | 1.8 | 2.1 | · | 2.1 | 2.2 | 3.4 | · | 5.4 | 6.1 | 7.5 | · | 8.9 | 11.6 | 9.0 | |
| Debt / Equity | -0.5 | -0.5 | · | -0.5 | -0.5 | -0.6 | · | -0.9 | -0.7 | -1.0 | · | -5.6 | 5.6 | -1.1 | |
| LT Debt / Equity | -0.5 | -0.5 | · | -0.5 | -0.5 | -0.6 | · | -0.9 | -0.7 | -1.0 | · | -5.6 | 5.6 | -1.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -4.4 | -4.1 | · | -3.5 | -3.3 | -3.3 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | 2.7 | 2.5 | · | 1.8 | 1.8 | 1.6 | · | 1.5 | 1.2 | 0.6 | · | · | · | · | |
| Receivables Turnover | 1.0 | 1.0 | · | 1.3 | 1.3 | 1.4 | · | 1.6 | 1.3 | 1.0 | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $222M | $176M | · | $134M | $92M | $54M | · | $26M | $9M | $2M | · | · | · | · | |
| Net Income TTM | $-154M | $-230M | · | $-286M | $-347M | $-354M | · | $-303M | $-259M | $-205M | · | $-173M | $-181M | $-180M | |
| Market Cap | $869M | $883M | · | $836M | $672M | $437M | · | $1.24B | $604M | $622M | · | $589M | $811M | $311M | |
| Enterprise Value | $851M | $865M | · | $908M | $728M | $428M | · | $1.08B | $502M | $448M | · | $475M | $660M | $278M | |
| P/E | -5.3 | -3.5 | · | -2.9 | -1.8 | -1.1 | · | -3.6 | -2.2 | -2.7 | · | -2.7 | -3.3 | -1.5 | |
| P/S | 3.9 | 5.0 | · | 6.2 | 7.3 | 8.1 | · | 48.3 | 65.4 | 325.1 | · | · | · | · | |
| P/B | -2.5 | -2.6 | · | -2.0 | -1.7 | -1.3 | · | -6.6 | -2.6 | -4.2 | · | -33.1 | 46.1 | -3.4 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 46.1 | · | |
| P / Cash Flow | · | -56.4 | · | · | · | -5.1 | · | · | · | -9.0 | · | · | · | -7.8 | |
| P / FCF | · | -56.2 | · | · | · | -5.1 | · | · | · | -9.0 | · | · | · | -7.8 | |
| EV / EBITDA | -214.6 | -56.3 | · | -59.5 | -12.1 | -5.4 | · | -15.2 | -6.5 | -6.4 | · | -13.3 | -20.8 | -9.3 | |
| EV / FCF | · | -55.1 | · | · | · | -5.0 | · | · | · | -6.5 | · | · | · | -7.0 | |
| EV / Revenue | 3.8 | 4.9 | · | 6.8 | 7.9 | 7.9 | · | 42.1 | 54.3 | 234.5 | · | · | · | · | |
| Earnings Yield | -18.8% | -28.3% | · | -34.8% | -54.6% | -89.5% | · | -28.0% | -44.5% | -36.8% | · | -36.7% | -30.6% | -64.6% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $175M | $55M | $682.0K | $0 | — |
| Bruttogewinnmarge % | 87.1% | 85.6% | 75.5% | — | — |
| Betriebsgewinnmarge % | -91.4% | -502.2% | -24532.5% | — | — |
| Nettoergebnis | $-221M | $-334M | $-202M | $-198M | $-144M |
| Verwässerte EPS | $-3.03 | $-5.29 | $-3.93 | $-5.05 | $-3.89 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | -0.5 | -0.8 | -1.9 | -1.3 | 1.2 |
| Liquiditätsgrad | 1.7 | 4.2 | 10.2 | 6.1 | 9.9 |
| Quick Ratio | 1.6 | 3.9 | 9.9 | 5.9 | 9.7 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-167M | $-267M | $-139M | $-148M | $-149M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 178 Einreicher · $617.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 33 (+1 vs. Vorquartal) | 30 (-5 vs. Vorquartal) | 51 (-22 vs. Vorquartal) | 50 (+13 vs. Vorquartal) | +3.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $135.261.406 | 12.466.489 | 21,91% | Aktien |
| Medicxi Ventures Management (Jersey) Ltd | $80.990.606 | 7.464.572 | 13,12% | Aktien |
| Carlyle Group Inc. | $37.940.367 | 3.496.808 | 6,15% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $36.627.799 | 3.375.834 | 5,93% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $28.827.842 | 2.656.944 | 4,67% | Aktien |
| NEA Management Company, LLC | $21.267.834 | 1.960.169 | 3,45% | Aktien |
| 683 Capital Management, LLC | $20.072.501 | 1.850.000 | 3,25% | Aktien |
| STATE STREET CORP | $17.211.605 | 1.586.323 | 2,79% | Aktien |
| Catalys Pacific, LLC | $16.208.316 | 1.493.854 | 2,63% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $15.871.000 | 1.462.738 | 2,57% | Aktien |
| GOLDMAN SACHS GROUP INC | $15.552.303 | 1.433.392 | 2,52% | Aktien |
| WASATCH ADVISORS LP | $14.897.577 | 1.340.916 | 2,41% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $12.271.034 | 1.130.751 | 1,99% | Aktien |
| Ensign Peak Advisors, Inc | $11.413.256 | 1.051.913 | 1,85% | Aktien |
| Propel Bio Management, LLC | $11.396.384 | 1.050.358 | 1,85% | Aktien |
| Point72 Asset Management, L.P. | $11.090.794 | 1.022.193 | 1,80% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8.643.446 | 796.631 | 1,40% | Aktien |
| SummitTX Capital, L.P. | $8.566.618 | 789.550 | 1,39% | Aktien |
| EcoR1 Capital, LLC | $6.781.250 | 625.000 | 1,10% | Aktien |
| PERCEPTIVE ADVISORS LLC | $5.772.200 | 532.000 | 0,94% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $5.631.975 | 519.076 | 0,91% | Aktien |
| CITADEL ADVISORS LLC | $5.216.680 | 480.800 | 0,85% | Kaufoption |
| VANGUARD GROUP INC | $4.969.501 | 299.548 | 0,81% | Aktien |
| StepStone Group LP | $4.689.364 | 422.085 | 0,76% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.547.170 | 419.094 | 0,74% | Aktien |
| Woodline Partners LP | $4.004.214 | 369.052 | 0,65% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $3.847.117 | 354.573 | 0,62% | Aktien |
| AMERIPRISE FINANCIAL INC | $3.189.358 | 293.950 | 0,52% | Aktien |
| Simplify Asset Management Inc. | $2.704.547 | 249.267 | 0,44% | Aktien |
| JPMORGAN CHASE & CO | $2.616.050 | 240.667 | 0,42% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $2.456.440 | 226.400 | 0,40% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.281.755 | 210.300 | 0,37% | Kaufoption |
| NewEdge Advisors, LLC | $2.212.988 | 203.962 | 0,36% | Aktien |
| Avidity Partners Management LP | $2.170.000 | 200.000 | 0,35% | Aktien |
| Jump Financial, LLC | $2.081.746 | 191.866 | 0,34% | Aktien |
| Opaleye Management Inc. | $2.013.641 | 185.589 | 0,33% | Aktien |
| CITADEL ADVISORS LLC | $2.006.176 | 184.901 | 0,32% | Aktien |
| Trexquant Investment LP | $1.886.641 | 173.884 | 0,31% | Aktien |
| Jones Hill Capital LP | $1.752.123 | 161.486 | 0,28% | Aktien |
| MARSHALL WACE, LLP | $1.751.191 | 161.400 | 0,28% | Aktien |
| XTX Topco Ltd | $1.473.777 | 135.832 | 0,24% | Aktien |
| DIADEMA PARTNERS LP | $1.409.958 | 129.950 | 0,23% | Aktien |
| SIG BROKERAGE, LP | $1.345.400 | 124.000 | 0,22% | Kaufoption |
| Engineers Gate Manager LP | $1.283.088 | 118.257 | 0,21% | Aktien |
| Virtus Investment Advisers, LLC | $1.216.708 | 112.139 | 0,20% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.178.885 | 108.653 | 0,19% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1.105.968 | 101.745 | 0,18% | Aktien |
| JANE STREET GROUP, LLC | $1.096.761 | 101.084 | 0,18% | Aktien |
| Stratos Wealth Partners, LTD. | $1.085.000 | 100.000 | 0,18% | Aktien |
| Swiss National Bank | $1.071.980 | 98.800 | 0,17% | Aktien |
| GILDER GAGNON HOWE & CO LLC | $956.254 | 88.134 | 0,15% | Aktien |
| Stonepine Capital Management, LLC | $922.358 | 85.010 | 0,15% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $838.879 | 77.316 | 0,14% | Aktien |
| JANE STREET GROUP, LLC | $837.620 | 77.200 | 0,14% | Kaufoption |
| BlackRock, Inc. | $835.548 | 77.009 | 0,14% | Aktien |
| Campbell & CO Investment Adviser LLC | $746.035 | 68.759 | 0,12% | Aktien |
| Penn Mutual Asset Management | $681.402 | 62.802 | 0,11% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $675.771 | 62.283 | 0,11% | Aktien |
| RHUMBLINE ADVISERS | $654.740 | 60.346 | 0,11% | Aktien |
| UBS Group AG | $635.105 | 58.535 | 0,10% | Aktien |
| Birchview Capital, LP | $596.750 | 55.000 | 0,10% | Aktien |
| D. E. Shaw & Co., Inc. | $585.206 | 53.936 | 0,09% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $547.612 | 49.290 | 0,09% | Aktien |
| CITIGROUP INC | $543.661 | 50.107 | 0,09% | Aktien |
| Bank of New York Mellon Corp | $540.037 | 49.773 | 0,09% | Aktien |
| Pale Fire Capital SE | $539.386 | 49.713 | 0,09% | Aktien |
| NOMURA HOLDINGS INC | $532.735 | 49.100 | 0,09% | Verkaufsoption |
| Man Group plc | $528.167 | 48.679 | 0,09% | Aktien |
| AlphaQuest LLC | $468.668 | 28.250 | 0,08% | Aktien |
| ADAR1 Capital Management, LLC | $465.465 | 42.900 | 0,08% | Aktien |
| Quantbot Technologies LP | $463.892 | 42.755 | 0,08% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $459.866 | 42.384 | 0,07% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $446.866 | 40.222 | 0,07% | Aktien |
| BARCLAYS PLC | $435.660 | 40.153 | 0,07% | Aktien |
| NOMURA HOLDINGS INC | $434.000 | 40.000 | 0,07% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $432.318 | 39.845 | 0,07% | Aktien |
| Fiduciary Trust Co | $387.681 | 35.731 | 0,06% | Aktien |
| Nebula Research & Development LLC | $363.816 | 37.937 | 0,06% | Aktien |
| Persistent Asset Partners Ltd | $359.753 | 33.157 | 0,06% | Aktien |
| ALLSTATE CORP | $356.694 | 32.875 | 0,06% | Aktien |
| Squarepoint Ops LLC | $342.806 | 31.595 | 0,06% | Aktien |
| CITADEL ADVISORS LLC | $337.435 | 31.100 | 0,05% | Verkaufsoption |
| VANGUARD ASSET MANAGEMENT, Ltd | $309.290 | 28.506 | 0,05% | Aktien |
| MetLife Investment Management, LLC | $304.961 | 28.107 | 0,05% | Aktien |
| Kera Capital Partners, Inc. | $291.062 | 26.826 | 0,05% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $280.342 | 25.838 | 0,05% | Aktien |
| Caption Management, LLC | $260.400 | 24.000 | 0,04% | Kaufoption |
| Caption Management, LLC | $260.400 | 24.000 | 0,04% | Verkaufsoption |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $245.720 | 22.647 | 0,04% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $244.500 | 22.535 | 0,04% | Aktien |
| Summit Financial Wealth Advisors, LLC | $240.252 | 22.143 | 0,04% | Aktien |
| JANUS HENDERSON GROUP PLC | $239.403 | 21.500 | 0,04% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $236.198 | 18.731 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $225.344 | 20.769 | 0,04% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $220.255 | 20.300 | 0,04% | Verkaufsoption |
| Invesco Ltd. | $211.065 | 19.453 | 0,03% | Aktien |
| INSPIRION WEALTH ADVISORS, LLC | $209.794 | 19.914 | 0,03% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $192.316 | 17.725 | 0,03% | Aktien |
| State of Wyoming | $191.383 | 17.639 | 0,03% | Aktien |
| PROFUND ADVISORS LLC | $187.455 | 17.277 | 0,03% | Aktien |
Unternehmensinsider 20 Insider · 9 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Steven L Basta | President and CEO | 10. Februar 2026 F | 373.315 | 0 | 0 | $0 |
| Molly Henderson | CFO and CBO | 7. April 2025 S | 89.868 | 0 | 0 | $0 |
| Todd P. Branning | Chief Financial Officer | 28. Januar 2021 A | — | 0 | 0 | $0 |
| Terrie Curran | President and Chief Executive | 27. Februar 2025 A | 360.465 | 0 | 0 | $0 |
| Azmi Nabulsi | Chief Operating Officer | 27. Februar 2025 A | 312.590 | 0 | 0 | $0 |
| Robert Charles Breedlove | Principal Accounting Officer | 14. Juli 2026 F | 59.925 | 0 | 2 | $-12.652 |
| Anne Marie Cook | Chief Legal Off. & Corp. Sec. | 10. Februar 2026 F | 88.660 | 0 | 0 | $0 |
| Sanjeev Narula | Chief Financial & Bus. Officer | 2. Januar 2026 A | 226.715 | 0 | 0 | $0 |
| Anthony J. Guzzo | VP, Chief Accounting Officer | 19. Januar 2022 A | 8.399 | 0 | 0 | $0 |
| Asit Parikh | Direktor | 22. Mai 2026 G | 148.500 | 0 | 0 | $0 |
| Mark Stenhouse | Direktor | 19. Mai 2026 A | 54.122 | 0 | 0 | $0 |
| Theodore R Schroeder | Direktor | 19. Mai 2026 A | 45.122 | 0 | 0 | $0 |
| James N. Topper | Direktor | 19. Mai 2026 A | 66.718 | 0 | 0 | $0 |
| Frank Karbe | Direktor | 19. Mai 2026 A | 91.622 | 0 | 0 | $0 |
| Michael F Cola | Direktor | 19. Mai 2026 A | 63.920 | 0 | 0 | $0 |
| Heidi Kunz | Direktor | 19. Mai 2026 A | 54.122 | 0 | 0 | $0 |
| David A Socks | Direktor | 23. Mai 2024 A | 19.500 | 0 | 0 | $0 |
| Tadataka Yamada | Direktor | 21. Mai 2021 A | — | 0 | 0 | $0 |
| Jonathan S. Edwards | Direktor | 29. Oktober 2019 C | 47.984 | 0 | 0 | $0 |
| Takeda Pharmaceutical Company Limited | — | 24. Januar 2024 S | 3.755.583 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×3 Einreichungen | 4. November 2025 | 8,60% | Änderung | — | SEC |
| Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes ×8 Einreichungen | 22. August 2024 | — | Erste Einreichung | — | SEC |
| Takeda Pharmaceutical Company Limited ×3 Einreichungen | 10. April 2024 | — | Erste Einreichung | — | SEC |
| Frazier Life Sciences IX, L.P ., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes | 26. Mai 2023 | — | Erste Einreichung | — | SEC |
| S.S. OR ×5 Einreichungen | 12. November 2021 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 34 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,23% | 64.997 NS | 30. April 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,01% | 11.659 NS | 30. April 2026 | N-PORT |
| IHE · iShares Trust | 0,09% | 182.732 SH | 8. August 2026 | Täglich |
| IWC · iShares Trust | 0,09% | 166.627 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,05% | 49.552 NS | 31. Mai 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 4.339 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 78.352 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,04% | 2.912 NS | 31. Mai 2026 | N-PORT |
| IBB · iShares Trust | 0,04% | 414.853 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 283.184 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 30.521 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,02% | 329.427 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 20.112 NS | 30. April 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 18.573 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 1.253.335 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,01% | 2.182 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 586.438 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 15.003 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 148.237 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 236.650 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 21.971 NS | 30. April 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 2.641 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 129.591 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,01% | 1.707 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1.727 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 2.570 SH | 8. August 2026 | Täglich |
| HDG · ProShares Trust | 0,00% | 43 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.333 NS | 31. Mai 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 205 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 79.259 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 33.490 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 9.288 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.007.668 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.478 SH | 8. August 2026 | Täglich |